Gene · 3159
Papers3,810
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,810
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic reprogramming shapes the immune microenvironment in pancreatic adenocarcinoma: prognostic implications and therapeutic targets. | Front Immunol | 2025 | 40191200 | PubTator, text mining | PubMed |
| Clinical efficacy and chemoresistance analysis of precision neoadjuvant chemotherapy for borderline resectable pancreatic cancer: a prospective, single-arm pilot study. | Int J Surg | 2025 | 40146255 | PubTator, text mining | PubMed |
| RNA-binding protein expression based machine learning model predicts metastasis and treatment outcome of testicular cancer. | Genes Genomics | 2025 | 40138122 | PubTator, text mining | PubMed |
| Case Report and Literature Review: Overexpression of HMGA in Concomitant Plurihormonal Tumor and Papillary Thyroid Carcinoma. | Neuropathology | 2025 | 40114328 | PubTator, text mining | PubMed |
| High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN Progression. | Int J Mol Sci | 2025 | 40076747 | PubTator, text mining | PubMed |
| Complicated crosstalk between HMGA and non-coding RNAs modulates hallmarks of cancer. | Cancer Cell Int | 2025 | 40055693 | PubTator, text mining | PubMed |
| Quantifying redox signalling regulatory transcriptional dynamics in Nardostachys jatamansi under abiotic stress response. | Biochim Biophys Acta Gen Subj | 2025 | 40054786 | PubTator, text mining | PubMed |
| FOSL1 drives the malignant progression of pancreatic cancer cells by regulating cell stemness, metastasis and multidrug efflux system. | J Transl Med | 2025 | 40038751 | PubTator, text mining | PubMed |
| The Role of HMGA1 and Height in Breast Cancer Risk and Prognosis: Insights from UK Biobank Data. | Cancer Diagn Progn | 2025 | 40034958 | PubTator, text mining | PubMed |
| The effect of simvastatin induced neurotoxicity on mitochondrial function in human neuronal cells. | Toxicol Mech Methods | 2025 | 40028788 | PubTator, text mining | PubMed |
| Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2. | J Exp Clin Cancer Res | 2025 | 40025525 | PubTator, text mining | PubMed |
| Activation of FGFR genes by genetic and epigenetic alterations in uterine leiomyomas. | BJC Rep | 2025 | 40016412 | PubTator, text mining | PubMed |
| Sigma-1 Receptor-Mediated High Mobility Group A1 Silencing Alleviates Endoplasmic Reticulum Stress-Induced Ovarian Granulosa Cell Apoptosis: An In Vitro Cell Experimental Study. | BJOG | 2025 | 39992005 | PubTator, text mining | PubMed |
| A method for the identification of lactate metabolism-related prognostic biomarkers and its validations in non-small cell lung cancer. | Sci Rep | 2025 | 39962075 | PubTator, text mining | PubMed |
| Study on the expression of S100A4 and HMGA1 in endometrial carcinoma and their correlation with metastasis. | Am J Transl Res | 2025 | 39959192 | PubTator, text mining | PubMed |
| BANCR-containing extracellular vesicles enhance breast cancer resistance. | J Biol Chem | 2025 | 39947472 | PubTator, text mining | PubMed |
| Multi-omic and machine learning analysis of mitochondrial RNA modification genes in lung adenocarcinoma for prognostic and therapeutic implications. | Transl Oncol | 2025 | 39908965 | PubTator, text mining | PubMed |
| PhosNetVis: A web-based tool for fast kinase-substrate enrichment analysis and interactive 2D/3D network visualizations of phosphoproteomics data. | Patterns (N Y) | 2025 | 39896259 | PubTator, text mining | PubMed |
| HMGA1 acts as an epigenetic gatekeeper of ASCL2 and Wnt signaling during colon tumorigenesis. | J Clin Invest | 2025 | 39895630 | PubTator, text mining | PubMed |
| IGF2BP3 is upregulated in endometrial cancer and tightly regulates the growth of drug-resistant endometrial cancer cells via HMGA1. | Sci Prog | 2025 | 39878052 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3159/papers?page=8